The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

S, Lüders; J, Schrader; J, Berger; T, Unger; W, Zidek; M, Böhm; M, Middeke; W, Motz; C, Lübcke; A, Gansz; L, Brokamp; RE, Schmieder; P, Trenkwalder; H, Haller; P, Dominiak

doi:10.1097/hjh.0b013e3282ff8864

Public

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

Shared by NobleBlocks on Jul 1, 2008 • 12:00 AM UTC

Authors:

Lüders S

Schrader J

Berger J

Abstract

Background The prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure study addresses the issue of whether progression to manifest hypertension in patients with high-normal blood pressure can be prevented with treatment.Method...

Discussions